Welcome to our dedicated page for BRIA news (Ticker: BRIA), a resource for investors and traders seeking the latest updates and insights on BRIA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BRIA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BRIA's position in the market.
BrilliA Inc (BRIA) has announced the pricing of its initial public offering, offering 2,500,000 Class A Ordinary Shares at $4.00 per share. The company expects to raise approximately $10 million in gross proceeds before deducting underwriting costs. BRIA has granted underwriters a 45-day option to purchase up to 375,000 additional shares. Trading is set to commence on NYSE American under ticker BRIA on November 27, 2024, with the offering expected to close on November 29, 2024. A.G.P./Alliance Global Partners is serving as the sole Book-Running manager for this firm commitment offering.
